Distinct mechanisms underlying therapeutic potentials of CD20 in neurological and neuromuscular disease
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference136 articles.
1. Autoimmune encephalitis: Proposed recommendations for symptomatic and long-term management;Abboud;Journal of Neurology, Neurosurgery, and Psychiatry,2021
2. Cutaneous improvement in refractory adult and juvenile dermatomyositis after treatment with rituximab;Aggarwal;Rheumatology (Oxford),2017
3. Necrosis in anti-SRP(+) and anti-HMGCR(+)myopathies: Role of autoantibodies and complement;Allenbach;NEUROLOGY,2018
4. Rituximab for the treatment of neuromyelitis optica spectrum disorder;Banerjee,2021
5. Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?;Bar-Or;Annals of Neurology,2010
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Low-dose rituximab regimen does not increase severe COVID-19 risk in patients with neuroimmune diseases during the pandemic: a cross-sectional study;2024-07-29
2. An angel or a devil? Current view on the role of CD8+ T cells in the pathogenesis of myasthenia gravis;Journal of Translational Medicine;2024-02-20
3. Clinical efficacy of anti-CD20 antibodies in autoimmune diseases;Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal;2024
4. Targeted Therapy for SLE—What Works, What Doesn’t, What’s Next;Journal of Clinical Medicine;2023-04-29
5. Simplified regimen of combined low-dose rituximab for autoimmune encephalitis with neuronal surface antibodies;Journal of Neuroinflammation;2022-10-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3